Sunnymeath Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Sunnymeath Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$543K	Sell	9,300 -1,100	-11%	-$60.1K	0.76%	54
2016 Q3	$437K	Sell	10,400 -2,200	-17%	-$141K	0.96%	49
2016 Q2	$928K	Hold	12,600	–	–	1.36%	34
2016 Q1	$809K	Hold	12,600	–	–	1.23%	40
2015 Q4	$867K	Buy	+12,600	New	+$833K	1.38%	37

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Sunnymeath Asset Management's BMY Position: Q4 2016 in Review

Sunnymeath Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q4 2016, selling an estimated $60.1K and leaving 9,300 shares worth $543K. The position accounts for 0.76% of the portfolio, ranked #54.

Sunnymeath Asset Management first reported a position in BMY in Q4 2015 and has held it in 5 quarters since. The position peaked at $928K in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Sunnymeath Asset Management held 9,300 shares of Bristol-Myers Squibb worth $543K as of Q4 2016.
Sunnymeath Asset Management sold 1,100 Bristol-Myers Squibb shares in Q4 2016, an estimated $60.1K.
Bristol-Myers Squibb made up 0.76% of Sunnymeath Asset Management's portfolio in Q4 2016, its #54 holding.
Sunnymeath Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 5 quarters since.
Sunnymeath Asset Management's Bristol-Myers Squibb position peaked at $928K in Q2 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Sunnymeath Asset Management's 13F filing for Q4 2016, filed 13 Jan 2017.